Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.
Right now, the IND-enabling studies are made to test the safety, tolerability, vector biodistribution, transgene expression, ...
Women’s eye health: The Fred Hollows Foundation's call for change this International Women’s Day
To tackle systemic barriers to eye care, the organization is co-hosting an event titled “No Woman Left Behind – Advancing Eye ...
The negative effects of smoking on ocular tissues are well known and include age-related macular degeneration (AMD), diabetic ...
Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging ...
Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and ...
Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...
At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating ...
At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into ...
Researchers conducted a first-of-a-kind cross-sectional study at the outpatient clinic of the Eye Hospital of China Academy ...
At the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing glaucoma in patients with other ocular co-morbidities such as myopia and those ...
Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback